Table 4.
RAD21 expression in breast cancers by intrinsic subtype
| Subtype |
negative
n (%) |
positive
n (%) |
Total
n (%) |
P-value
Relative to luminal |
|---|---|---|---|---|
| Luminal | 126 (63%) | 75 (37%) | 201 (100%) | - |
| Basal-like | 32 (76%) | 10 (24%) | 42 (100%) | 0.095 |
| HER2 | 38 (78%) | 11 (22%) | 49 (100%) | 0.050 |
| Null | 23 (82%) | 5 (18%) | 28 (100%) | 0.043 |
| Total | 239 (70%) | 104 (30%) | 320 (100%) | |